ASHLEY ZAUSCH: Open Payments
NPI 1568739639 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 66 payments from 21 companies in 2025. Trend: 2023 $381 · 2024 $1,244 · 2025 $1,525
Food & beverage: $1,513Education: $12
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $325 |
| Gilead Sciences, Inc. | 7 | $323 |
| Daiichi Sankyo Inc. | 9 | $195 |
| Merck Sharp & Dohme LLC | 6 | $105 |
| Lilly USA, LLC | 4 | $75 |
| ABBVIE INC. | 3 | $61 |
| Janssen Biotech, Inc. | 2 | $51 |
| PFIZER INC. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| GENZYME CORPORATION | 2 | $45 |
Products named: Trodelvy, KISQALI, DATROWAY, VENCLEXTA, VERZENIO, KEYTRUDA, Enhertu, IBRANCE.
Industry payments across KY — which companies pay providers there.
